Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Espinoza Octavio sold 31,641 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Espinoza Octavio (Chief Financial Officer) sold 31,641 Ligand Pharmaceuticals Incorporated shares at US$292.07 for US$9.24M under a trading plan, leaving 27,696 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 31,641 shares
- Price
- US$292.07
- Value
- US$9.24M
- Holding after
- 27,696 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 16,179 | US$52.84 | 43,875 | Direct |
| Aug 12, 2026 | Common Stock | Option exercise | 2,074 | US$70.04 | 45,949 | Direct |
| Aug 12, 2026 | Common Stock | Option exercise | 2,869 | US$55.75 | 48,818 | Direct |
| Aug 12, 2026 | Common Stock | Option exercise | 7,171 | US$57.22 | 55,989 | Direct |
| Aug 12, 2026 | Common Stock | Option exercise | 3,348 | US$68.74 | 59,337 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 31,641 | US$292.07 | 27,696 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Espinoza Octavio
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Espinoza Octavio · Jul 6, 2026
- Form 4 · Espinoza Octavio · May 28, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Haas Jason · Aug 14, 2026